NCT04171115View on ClinicalTrials.gov

Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

August 20, 2022

Study Completion Date

April 5, 2023

Conditions
Healthy
Interventions
DRUG

G03-52-01

G03-52-01 administered intramuscularly

DRUG

Placebo

Placebo administered intramuscularly

Trial Locations (1)

78209

ICON Early Phase Services, San Antonio

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Alachua Government Services, Inc.

INDUSTRY

NCT04171115 - Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects | Biotech Hunter | Biotech Hunter